Kiwi fruit
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Bass Oil (ASX:BAS) shareholders were relieved on Monday when the company said its Kiwi-1 extended production test (EPT) is set for October 18 – shares were up +10% to 7.7cps in the second hour of trade.

Bass Oil has repeatedly announced updates on the ETP through the calendar year going back to March 2024 when project approvals were confirmed.

Kiwi-1 was originally drilled in 2003 and clocked a flow test rate of 9.6Mcfpd of gas in drill stem testing. Bass is hoping it can replicate those results in an ETP 21 years later; the geological age of that result was determined to be Triassic.

Should it be successful in proving there’s gas underground, the microcap believes it has a fair shot at cracking its way into the east coast gas supply chain. Beach Energy on Monday reported its internal calculations suggesting supply will fall -30% by the early 2030’s on current levels.

Despite those claims being contested in some quarters of Australia’s energy ecosystem, Bass MD Tino Guglielmo pointed at the same prediction on Monday – and with the population steadily increasing, increased demand is guaranteed.

“A success at Kiwi will be highly value accretive to Bass proving up the Company’s first gas reserves at a time of elevated pricing due to predicted Eastern Gas Market shortages,” Guglielmo said.

“This test will confirm the commerciality of this important gas discovery.”

BAS last traded at 7.7cps.

BAS by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…